Kovai Medical Center and Hospital (KMCH), the 657-bed Multi-disciplinary advanced Super specialty hospital located in a clean, serene 20 acre plot in Coimbatore offers total and comprehensive health solution for various diseases. Comprehensive infrastructure, cutting edge technology, latest Hi â Tech medical equipments in all specializations and committed medical experts make KMCH trusted brand. The hospital has pioneered several techniques like the steroid free kidney transplantation, GDC coiling and clipping for brain aneurysms which save lives, improve patient comfort and minimize side effects.
The hospital has 20 operation theatres and modern equipments including state of the art Varian Trilogy Linear Accelerator, worldâs most advanced PET-CT Scan, 3T MRI, 500 slice volume CT scanner, Endo Bronchial Ultra sound (EBUS), 4D Ultra Sound Scanner, Flat Panel Cath Lab, Cardiac Electro-physiology Lab, Bone Mineral Densitometer, Mammography, Laser equipments, Video Endoscope, Operating Microscope, Auto analyzer, Computer Assisted Navigation for hip and knee replacements, ESWL for the removal of urinary stones.
Super specialty procedures like Open heart surgeries, Valve replacements, Kidney transplants, Hip and Knee replacements, Complex Brain surgeries and Advanced Spine surgeries are done regularly at the hospital.
At KMCH, the latest edition has been the state of the art Comprehensive Cancer Center. The hospital offers 24 hrs end to end services in cancer care from prevention to early detection, comprehensive treatment to palliative care under one roof.
The Comprehensive Cancer center equipped with the worldâs most advanced PET-CT Scanner-True-point enabled Siemens Bio graph 6 for the first time in Coimbatore & Western Tamil Nadu. This unique instrument; PET-CT Scanner makes KMCH one of the few centers in the world to provide this form of cutting edge technology for cancer care. Cancer treatment requires accurate staging of the disease by demonstrating its spread in the human body. The therapies of cancer differ from patient to patient and cure is possible only with perfect staging. World over the whole body PET-CT is the gold Standard for cancer staging. A PET-CT not only stages cancer but it is the current choice for evaluating treatment response and disease recurrence in Oncology.
Highly Qualified and experienced team of professionals in KMCH offers advanced radiation treatment for Cancer control and cure. This hospital provides Rapid Arc therapy with IMRT, image Guided Radio Therapy, SRS, 4D gated Radiotherapy & SBRT.
The Hospital has over 150 internationally renowned full time specialists and over 250 post graduate medical professionals assisting them. With more then 1500 medical, Paramedical, patient relations and administrative staff, the hospital offers total care for patients.
Continuing Medical Education programs update skill sets of the doctors and paramedical staff and keep them abreast of the latest developments in their field. The services are integrated by a state of the art Hospital Management System to provide effortless patient movement.
There are three satellite centers attached to KMCH :
City Center (Ram Nagar)
Erode Speciality Hospital (100 bed)
Erode Center (100 bed) with both in-patient and out patient facilities It has a rural health center at Veeriampalayam to serve the rural community and the under privileged.
Financials:
Yearly
Expected
Expected
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Sales
87.54
110.36
130.07
174.64
222.37
300
330-360
Operating Profit
14.42
18.33
25.75
37.07
43.76
80
90-100
Interest
3.82
4.5
5.68
12.16
16.96
30
Depreciatin
3.85
3.92
4.69
6.63
12.13
15
PBT
8.14
11
17.24
19.48
16.24
35
tax
2.89
3.89
5.75
7.43
4.29
12
NP
5.25
7.14
11.59
12.1
11.95
23
30-40
Quarterly
Dec-12
Sep-12
Jun-12
Mar-12
Dec-11
Sales
79.3
68.2
60.14
57.61
Operating Profit
21.87
16.18
10.95
12.53
Interest
7.02
7.23
4.37
4.84
Depreciatin
3.93
3.7
3.54
3.03
PBT
10.92
5.25
3.03
4.66
tax
3.79
1.67
0.73
1.27
NP
7.12
3.58
2.3
3.39
Cash Flows
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Operating cash flow
12.52
14.8
23.9
41.2
55.9
Stock Price: 175, P/E:10 Mcap: 191, P/E(FY13): 8 ,
D/E: 3+, D/E(FY13) = 2+
Compounded Sales Growth | |
10 Years: | 23.04% |
5 Years: | 24.59% |
3 Years: | 26.31% |
1 Year: | 31.21% |
Compounded Profit Growth | |
10 Years: | 39.43% |
5 Years: | 12.54% |
3 Years: | 18.90% |
1 Year: | 5.54% |
Return on Equity | |
10 Years: | 23.87% |
5 Years: | 25.74% |
3 Years: | 26.15% |
1 Year: | 21.37% |
Investment Theme:
Recession proof, Growing business (Industry growuth 14%) and sustainable services for cash business. No inventories. No Debtors. No Worries.
PE rerating is a possibility as other listed players like Apollo command P/E:40.
IMO, Expecting a 3-5 bagger in2-4 years in a bull market situation
Negatives: High Debt and capital intensive.
Requesting senior valuepickers opinion.
Disc: Invested a small amount.